专题:PI3K/AKT/mTOR signaling in cancer

This cluster of papers focuses on the mTOR signaling pathway, particularly its role in growth control, metabolism, and disease, with a specific emphasis on cancer. The PI3K/AKT pathway, Raptor, TSC2, and rapamycin are central to the research discussed in these papers.
最新文献
近5年高被引文献
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer

review Full Text OpenAlex 1928 FWCI261.1629

Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease

review Full Text OpenAlex 873 FWCI118.5443

PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?

review Full Text OpenAlex 777 FWCI60.1506

Capivasertib in Hormone Receptor–Positive Advanced Breast Cancer

article Full Text OpenAlex 714 FWCI163.6777

Pan-KRAS inhibitor disables oncogenic signalling and tumour growth

article Full Text OpenAlex 502 FWCI68.2815

mTOR substrate phosphorylation in growth control

review Full Text OpenAlex 434 FWCI32.1701

Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update

review Full Text OpenAlex 369 FWCI130.0482

EGFR signaling pathway as therapeutic target in human cancers

review Full Text OpenAlex 340 FWCI41.8604

Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy

article Full Text OpenAlex 321 FWCI60.3452

Signaling pathways and therapeutic interventions in gastric cancer

review Full Text OpenAlex 312 FWCI38.773